• Extension of Tissue Plasminogen Activator Treatment Window by Granulocyte-Colony Stimulating Factor in a Thromboembolic Rat Model of Stroke. International Stroke Conference, Los Angeles, USA (01/2018)
  • Cognitive enhancing effect of pharmacogenetic excitation of pyramidal neurons in the rat prefrontal cortex (05/2018)
  • Decreased p-glycoprotein expression associated with delayed tPA treatment in rats subjected to embolic stroke (05/2018)
  • White matter microstructural alterations in the combined and primarily inattentive animal models of attention-deficit/ hyperactivity disorder (ADHD) (05/2018)
  • Droxidopa ameliorates attention deficit hyperactivity disorder-like behaviors in rats and alters activity of prefrontal cortex and dopamine neurons in the ventral tegmental area.European Network on Hyperkinetic Disorders 2018, Edinburgh, UK  (09/2018)
  • Disrupted Hippocampal Maturation and Neuregulin-ErbB4 Signaling in Rats exposed to a Short-term High-Fat/High-Sugar Diet (08/2019)
  • Differential Activity and Functional Coupling to the Prefrontal cortex of Dopamine Neurons in the Ventral Tegmental Area in the WKY/NCrl and SHR/NCrl Animal Models of ADHD. CINP Meeting 2019, Athens, GREECE (10/2019)
  • Endocrine and Metabolic Alterations in Rats Exhibiting High Anxiety-Related Behaviors  (11/2019)
  • Enhancing Cognitive Resilience in Response to Early-life Stress and Obesity Presented at Sahmyook University, South Korea (03/2020)
  • Neurobiology of ADHD: New Insights from Animal Models Physiology Seminar Series- Tulane University, NO, Louisiana (08/2020)
  • The Search for Genetic Markers of ADHD Presented during the Pharmacy Week Celebration of Manila Adventist College,  Manila, Philippines (12/2020)